Moderna Inc MRNA:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 5:32 AM EDT
429.06quote price arrow up+5.73 (+1.35%)
Volume
8,745
Close
423.33quote price arrow down-6.72 (-1.56%)
Volume
12,131,266
52 week range
63.64 - 497.49
Loading...
  • Open417.51
  • Day High435.45
  • Day Low416.51
  • Prev Close423.33
  • 52 Week High497.49
  • 52 Week High Date08/10/21
  • 52 Week Low63.64
  • 52 Week Low Date09/24/20

Key Stats

  • Market Cap170.877B
  • Shares Out403.65M
  • 10 Day Average Volume16.01M
  • Dividend-
  • Dividend Yield-
  • Beta1.51
  • YTD % Change305.22

KEY STATS

  • Open417.51
  • Day High435.45
  • Day Low416.51
  • Prev Close423.33
  • 52 Week High497.49
  • 52 Week High Date08/10/21
  • 52 Week Low63.64
  • 52 Week Low Date09/24/20
  • Market Cap170.877B
  • Shares Out403.65M
  • 10 Day Average Volume16.01M
  • Dividend-
  • Dividend Yield-
  • Beta1.51
  • YTD % Change305.22

RATIOS/PROFITABILITY

  • EPS (TTM)8.01
  • P/E (TTM)52.84
  • Fwd P/E (NTM)9.62
  • EBITDA (MRQ)3.918B
  • ROE (MRQ)72.43%
  • Revenue (MRQ)7.02B
  • Gross Margin (MRQ)84.20%
  • Net Margin (MRQ)49.79%
  • Debt To Equity (MRQ)7.26%

EVENTS

  • Earnings Date10/27/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Related Video

VIDEO3:3703:37
Pfizer, Moderna report positive topline results for vaccine in ages 5-11

Profile

MORE
Moderna, Inc. is a biotechnology company that is focused on creating a transformative medicines based on messenger RNA (mRNA). The Company’s mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane, or secreted proteins that have a therapeutic or preventive benefit with the potential to address a range of spectrum of diseases. The Company develops technologies that enable the development of mRNA medicines for diverse applications. The Company...
Noubar Afeyan Ph.D.
Non-Executive Chairman
Stephane Bancel
Chief Executive Officer
Stephen Hoge M.D.
President
David Meline
Chief Financial Officer
Juan Andres
Chief Technology Officer
Lori Henderson J.D.
General Counsel
Address
200 Technology Sq
Cambridge, MA
02139-3578
United States

Top Peers

SYMBOLLASTCHG%CHG
BNTX
BioNTech SE
339.01-20.17-5.62%
ILMN
Illumina Inc
438.00-9.01-2.02%
REGN
Regeneron Pharmaceuticals Inc
640.89-10.99-1.69%
BIIB
Biogen Inc
298.49-1.70-0.57%
GRFS
Grifols SA
15.41+0.02+0.13%